Sources | Names Used |
---|---|
CCLE, FIMM | Vandetanib |
CTRPv2 | vandetanib |
PharmacoGx | Vandetanib |
Database | Identifier |
---|---|
Smiles: | CN1CCC(CC1)COC2=C(C=C3C(=C2)N=CN=C3NC4=C(C=C(C=C4)Br)F)OC |
Inchikey: | UHTHHESEBZOYNR-UHFFFAOYSA-N |
Pubchem: | 3081361 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BCL2L12 | CCLE | pan-cancer | AAC | 0.13 | 0.008 |
mRNA | CEP89 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | DLGAP4 | CCLE | pan-cancer | AAC | -0.14 | 0.008 |
mRNA | NUSAP1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.008 |
mRNA | GLTSCR2 | CCLE | pan-cancer | AAC | 0.15 | 0.008 |
mRNA | PIK3R1 | FIMM | pan-cancer | AAC | 0.5 | 0.008 |
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.008 |
mRNA | MED21 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.008 |
mRNA | DYRK3 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | STK33 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |